• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Credit Suisse Lux Biotechnology Equity Fund

+ Add to Watchlist

CR4A:GR

291.9600 EUR 11.3600 4.05%

As of 15:45:03 ET on 10/21/2014.

Snapshot for Credit Suisse Lux Biotechnology Equity Fund (CR4A)

Open: 283.5300 High - Low: 292.2200 - 280.6300 Primary Exchange: Berlin
Volume: 0 52-Week Range: 201.6000 - 297.5000 Beta vs NBI: 0.9317

ETF Chart for CR4A

No chart data available.
  • CR4A:GR 283.4770
  • 1D
  • 1M
  • 1Y
280.6000
Interactive CR4A Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CR4A

Credit Suisse Lux Biotechnology Equity Fund is a SICAV incorporated in Luxembourg. The Fund is actively managed aiming to outperform the return of the NASDAQ Biotechnology TR benchmark. The Fund mainly invests in equity and equity-type securities of issuers engaged in the biotechnology industry.

Inception Date: 2001-11-06 Telephone: -
Managers: IRENE BEATRICE PUETTNER
Web Site: www.credit-suisse.com

Fundamentals for CR4A

NAV -
Assets (M) (on 2014-10-20) 199.4284
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for CR4A

No dividends reported

Performance for CR4A

1-Month -3.11% 1-Year +34.72%
3-Month +17.28% 3-Year +41.46%
Year To Date +24.18% 5-Year +27.06%
Expense Ratio -

Top Fund Holdings for CR4A

Filing Date: 07/31/2014
Name Position Value % of Total
Gilead Sciences Inc 185,484 16,981,060 8.907%
Celgene Corp 180,276 15,711,053 8.241%
Biogen Idec Inc 42,745 14,293,501 7.497%
Amgen Inc 111,973 14,264,240 7.482%
Alexion Pharmaceuticals Inc 61,752 9,817,950 5.150%
Regeneron Pharmaceuticals Inc 28,000 8,854,160 4.644%
Vertex Pharmaceuticals Inc 94,000 8,357,540 4.384%
BioMarin Pharmaceutical Inc 114,444 7,074,928 3.711%
Incyte Corp 125,000 5,946,250 3.119%
Medivation Inc 80,000 5,938,400 3.115%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil